China officially granted emergency use approval for the inactivated COVID-19 vaccine developed by Sinopharm for people aged three to 17, Sinopharm said on July 16. Professor Huang Jie from Peking University School of Public Health talks about how this method will affect China's inoculation program. He said parents in China should rest assured that a robust vaccination system is in place.